Variagenics' Unattributed VC - II Round

Variagenics raised a round of funding on March 20, 2000.

Variagenics, Inc. applies its pharmacogenomic technologies to the discovery, development and commercialization of personalized drugs and companion molecular diagnostic products. Using a targeted drug …

Articles about Variagenics' Unattributed VC - II Round: